Northwest Biotherapeutics, Inc Dives Midday, Perhaps Starting to Feel the Heat

BioDelivery Sciences International, Inc. (NASDAQ:BDSI), InvenSense Inc (NYSE:INVN) and Discovery Laboratories, Inc. (NASDAQ:DSCO) kicked off the week strong and are this Monday’s top midday gainers. Adept Technology Inc (NASDAQ:ADEP), Northwest Biotherapeutics, Inc (NASDAQ:NWBO) and NanoString Technologies Inc (NASDAQ:NSTG) are the losers.

BioDelivery Sciences Surges on Positive Drug Trial Results

Today’s top midday gainer is BioDelivery Sciences International, Inc. (NASDAQ:BDSI), is a development-stage biotechnology company. Its price climbed +10.12% on positive drug trial results. Billionaire Julian Robertson has owned 511,000 BDSI shares since the fourth quarter of 2013.

David Einhorn Buys Three New Stocks: These Are The Names And Theses (Q3 Letter)

david einhorn, reading, valuewalk, internet, investment research, Greenlight Capital, hedge funds, Greenlight Masters, famous hedge fund owners, big value investors, websites, books, reading financials, investment analysis, shortselling, investment conferences, shorting, short biasDavid Einhorn's Greenlight Capital funds returned 5.9% in the third quarter of 2020, compared to a gain of 8.9% for the S&P 500 in the same period. This year has been particularly challenging for value investors. Growth stocks have surged as value has struggled. For Greenlight, one of Wall Street's most established value-focused investment funds, Read More

InvenSense Inc (NYSE:INVN) also got a strong start to the day, up +7.07%. The motion technology company has been generating quite a bit of buzz as of late and has many investors, including George Soros, excited. Its price is up +15.5% YTD and +52.87% over the past year.

Rounding out today’s list of midday gainers is Discovery Laboratories, Inc. (NASDAQ:DSCO), the price of which surged +5.88%. A new Q1 pick for Soros, DSCO has struggled in 2014 and is down -11.56% YTD, though it has rebounded +17.06% over the last month.

Northwest Biotherapeutics Dips

Adept Technology Inc (NASDAQ:ADEP) posted a loss of -8.71% midday today, continuing a bad 2014 run. The share price of the Q1 Soros acquisition has declined -41.23% year-to-date.

Northwest Biotherapeutics, Inc (NASDAQ:NWBO), also a new first quarter buy for Soros, dipped -8.68%. The biotech firm has proven an interesting case to follow in 2014, as the company has embarked on a massive promotional campaign that has some analysts crying foul. And at the start of this month, Glancy Binkow & Goldberg LLP announced that it was investigating potential investor claims. The stock is up +72.68% YTD.

Down -8.45%, NanoString Technologies Inc (NASDAQ:NSTG) rounds out today’s list of midday losers. This is yet another new Q1 buy for billionaire hedge fund manager George Soros. Its price has declined -7.59% over the past month.